Cancer Fund I, LLC
Our first community investment fund — supporting early-stage companies advancing diagnostics, therapeutics, and care.
The opportunity, by the numbers
Our pipeline includes more than 1,000 early-stage cancer companies seeking investment. We track diagnostics, therapeutics, and care platforms across cancer types, with new innovations entering the pipeline as we deepen relationships with researchers, founders, and institutional partners.
We cannot fund all of them. That is the point of a fund — selection. Our community helps us evaluate where capital does the most good.
Pipeline size: 1,000+ companies
If you are a cancer innovator seeking funding, we invite you to submit your profile for investment consideration HERE.
What Cancer Fund I, LLC invests in
Cancer Fund I, LLC supports early-stage cancer companies advancing diagnostics, therapeutics, and care — from pre-seed through later stages. The range matters. Different cancers, different patient populations, and different commercial pathways need different kinds of capital. A fund that invests across stages can support an innovation when the timing fits, not when an arbitrary investment thesis says so.
Selection runs through our community. Our screening committee — oncologists, scientists, industry professionals, and patient advocates — works alongside the fund investment team to evaluate opportunities. The community is part of the diligence, not a marketing claim.
For current fund terms, target raise, minimum investment, and accreditation requirements, see Cancer Fund I Details.
The path to potential returns
Cancer Fund I invests in early-stage cancer companies. If those companies achieve a liquidity event — typically an acquisition or initial public offering (IPO) — the fund may sell its ownership stake, ideally for more than we invested. When that happens, the fund either reinvests those proceeds into the portfolio or distributes them to our investors per the fund’s operating agreement.
Cancer Fund I, LLC is offered only to verified accredited investors under SEC Rule 506(c). For specific terms, see Cancer Fund I Details.
Returns described here apply only to investments in Cancer Fund I, LLC. Charitable contributions to the CANCER FUND Community Donor-Advised Fund — held at ImpactAssets, Inc., a 501(c)(3) public charity — are not investments and do not generate returns to donors or grantmakers.
Transparency, by default
Cancer Fund I, LLC investors see what we see. Our standard reporting includes:
- Investment summaries explaining why we backed each portfolio company, in plain language rather than technical shorthand.
- Founder and innovator interviews introducing the people behind the portfolio.
- Annual reporting on portfolio progress, capital deployed, and outcomes — both impact and financial.
Get involved
If you are an accredited investor, Cancer Fund I, LLC is offered under Rule 506(c). If you are supporting the work through charitable giving, the CANCER FUND Community Donor Advised Fund at ImpactAssets is open to anyone.
I want to INVEST to support cancer innovation
Verified accredited investors only; see subscription documents for current minimum and terms
I represent a FAMILY OFFICE, FOUNDATION, or INSTITUTIONAL investor
Explore investment and partnership opportunities
I want to GIVE to support cancer innovation
Donate by credit or debit card or donor-advised fund (DAF) grant; open to everyone
I want to JOIN THE COMMUNITY to follow the future of cancer care
Free to join and follow the innovations moving beyond the lab to patients